Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cyclerion Therapeutics (CYCN) Receivables - Other (2019 - 2020)

Historic Receivables - Other for Cyclerion Therapeutics (CYCN) over the last 2 years, with Q4 2020 value amounting to $127000.0.

  • Cyclerion Therapeutics' Receivables - Other fell 9138.4% to $127000.0 in Q4 2020 from the same period last year, while for Dec 2020 it was $127000.0, marking a year-over-year decrease of 9138.4%. This contributed to the annual value of $127000.0 for FY2020, which is 9138.4% down from last year.
  • Per Cyclerion Therapeutics' latest filing, its Receivables - Other stood at $127000.0 for Q4 2020, which was down 9138.4% from $400000.0 recorded in Q3 2020.
  • In the past 5 years, Cyclerion Therapeutics' Receivables - Other registered a high of $1.9 million during Q2 2019, and its lowest value of $127000.0 during Q4 2020.